The 2016 - 2017 flu season is well under way across the United States. While seasonal flu viruses can be detected year-round, the Center for Disease Control (“CDC”) reports that cases are often seen October through May, with the most occurring between December and March. Recently, the CDC issued interim findings of flu vaccine efficacy based on data from November 28, 2016 through February 4, 2017. During this timeframe, and based on 3,144 children and adults, the 2016-2017 vaccine effectiveness is currently 48%. This is substantially similar to the 2015-2016 season when vaccine effectiveness was 47% but is far greater that the 2014-2015 season when effectiveness was only 19%. Therefore, this year’s vaccine formula reduces the risk for influenza associated medical visits by approximately half. In addition, the CDC also reports that we can expect increased flu activity for several more weeks and continues to recommend unvaccinated people who are 6 months or older to get the flu vaccine.
While the vast majority of those who receive the flu vaccine experience no adverse reaction, adverse reactions to the flu shot do occur. If you think you or someone you know has been injured by a vaccine, compensation for the injury may be available. To find out if you qualify to file a case under the National Vaccine Injury Compensation Program, please contact our VICP attorneys.
While the vast majority of those who receive the flu vaccine experience no adverse reaction, adverse reactions to the flu shot do occur. If you think you or someone you know has been injured by a vaccine, compensation for the injury may be available. To find out if you qualify to file a case under the National Vaccine Injury Compensation Program, please contact our VICP attorneys.